Paula T. Einhorn

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei et al. · JAMA · 1995 · 605 citations

Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality

Paul Muntner, Jeff Whittle, Amy I. Lynch et al. · Annals of Internal Medicine · 2015 · 301 citations

Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Barry R. Davis, John B. Kostis, Lara M. Simpson et al. · Circulation · 2008 · 204 citations · Full text

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

L. Julian Haywood, Charles E. Ford, Richard S. Crow et al. · Journal of the American College of Cardiology · 2009 · 180 citations

Hypertension, Lipid-lowering Treatment, Cardiovascular Disease +10

Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

William C. Cushman, Charles E. Ford, Paula T. Einhorn et al. · Journal of Clinical Hypertension · 2008 · 88 citations · Full text